BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Capecitabine

A deoxycytidine derivative and fluorouracil PRODRUG that is used as an ANTINEOPLASTIC ANTIMETABOLITE in the treatment of COLON CANCER; BREAST CANCER and GASTRIC CANCER.

297+ PubMed studies analyzed · 12 RCTs · Evidence Score: 47.3

Research Domains

Capecitabine has been studied across 11 research domains including 🔬 Oncology, ⏳ Longevity & Aging, ✨ Skin & Hair, 🫁 Liver & Detox, 🧬 Hormones. The primary research focus is 🔬 Oncology with 70% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Capecitabine, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Cytarabine
2 shared targets
gentiana
2 shared targets
lycopus
2 shared targets
lithospermum
2 shared targets
platycodon
2 shared targets
allium
2 shared targets
alisma
2 shared targets
allium
2 shared targets
quisqualis
2 shared targets
saposhnikovia
2 shared targets
Loading evidence profile...

This evidence profile for Capecitabine is generated deterministically from 297 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.